What Is The Cost Of A Course Of Treatment With Tyvyt (Sintilimab Injection)?

Tyvyt, also known as sintilimab injection, is a medication commonly used in the treatment of several types of cancers. A full course of treatment with sintilimab injection typically costs between $2,000 and $3,000. However, the exact price may vary depending on the region and the specific medical facility. It is important to note that sintilimab is currently used in China for the treatment of relapsed classical Hodgkin lymphoma after second-line systemic chemotherapy. It can also be used in combination with other medications for the treatment of squamous cell lung cancer, small cell lung cancer, or unresectable liver cancer in patients who have not previously received systemic treatment.

In recent updates, sintilimab injection has undergone a new round of price reductions. Each vial of the medication now costs approximately $1,000. Since a standard treatment cycle usually involves the use of two vials, the total cost for one course of treatment generally falls within the $2,000 to $3,000 range. Most medical centers will ensure that the total cost for a two-vial course does not exceed $3,000. With the updated pricing and its inclusion in national health insurance programs, the financial burden on patients has been significantly reduced. This allows more patients to access and benefit from sintilimab treatment.

Despite its therapeutic benefits, sintilimab injection may cause certain side effects. Common complications include fever, anemia, and abnormal thyroid function. Additionally, it may lead to unique immune-related adverse reactions such as immune-mediated pneumonitis, diarrhea, and colitis. It is crucial for patients to be closely monitored during treatment for any signs of adverse effects, and prompt medical intervention should be provided when necessary.